INVESTIGADORES
RABINOVICH Gabriel Adrian
artículos
Título:
GALECTIN-1 AS A POTENTIAL CANCER TARGET
Autor/es:
GABRIEL A. RABINOVICH
Revista:
BRITISH JOURNAL OF CANCER
Editorial:
Nature Publishing Group
Referencias:
Lugar: London, UK; Año: 2005 vol. 92 p. 1188 - 1192
ISSN:
0007-0920
Resumen:
Galectins are a family of structurally related carbohydrate-binding proteins, which are defined by their affinity for poly-N-acetyllactosamine-enriched glycoconjugates and sequence similarities in the carbohydrate recognition domain. Galectin-1, a member of this family, contributes to different events associated with cancer biology including tumour transformation, cell cycle regulation, apoptosis, cell adhesion, migration and inflammation. In addition, recent evidence indicates that galectin-1 contributes to tumor evasion of immune responses. Given the increased interest of tumour biologists and clinical oncologists in this field and the potential use of galectins as novel targets for anti-cancer drugs, we summarize here recent advances about the role of galectin-1 in different events of tumour growth and metastasis.